Breast cancer invasion is mediated by β-N-acetylglucosaminidase (β-NAG) and associated with a dysregulation in the secretory pathway of cancer cells

British Journal of Biomedical Science

Volumn 67, Issue 4, 2010, Pages 189-196

  Ramessur, K T ^a   Greenwell, P ^a   Nash, R ^b   Dwek, Miriam V ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

Glycoside hydrolases; Lysosomes; Matrigel; Neoplasm invasion; Neoplasms; Peptide hydrolases; Secretory pathway; Steviamine

Indexed keywords

MATRIGEL; N ACETYL BETA GLUCOSAMINIDASE;

ACIDITY; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER INVASION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LYSOSOME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 79551570324     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2010.11730318     Document Type: Article

References (30)

1. Lah TT, Durán Alonso MB, Van Noorden CJ. Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 2006; 6 (3): 257-79.
2. Roy M, Marchetti D. Cell surface heparin sulphate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 2009; 106 (2): 200-9.
3. Lokeshwar VB, Cerwinka WH, Lokeshwar BL. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res 2005; 65 (6): 2243-50.
4. Henrissat B, Davies G. Structural and sequence-based classification of glycoside hydrolases. Curr Opin Struct Biol 1997; 7 (5): 637-44.
5. Elbein AD. Inhibitors of glycoprotein synthesis. Methods Enzymol 1983; 98: 135-54
6. Bosmann HB, Hall TC. Enzyme activity in invasive tumors of human breast and colon. Proc Natl Acad Sci USA 1974; 71 (5): 1833-7.
7. Gil-Martin E, Gil-Seijo S, Nieto-Novoa C, Fernandez-Briera A. Elevation of acid glycosidase activities in thyroid and gastric tumors. Int J Biochem Cell Biol 1996; 28 (6): 651-7.
8. Gil-Martin E, Rodriguez-Berrocal J, Paez de la Cadena M, Fernandez-Briera A. Alterations of glycosidases in human colonic adenocarcinoma. Clin Biochem 1997; 30 (1): 17-25. (Pubitemid 27097704)
9. Niedbala MJ, Madiyalakan R, Matta K, Crickard K, Sharma M, Bernacki RJ. Role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix. Cancer Res 1987; 47 (17): 4634-41.
10. Woynarowska B, Skrincosky DM, Haag A, Sharma M, Matta K, Bernacki RJ. Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J Biol Chem 1994; 269 (36): 22797-803.
11. Woynarowska B, Wikiel H, Bernacki RJ. Human ovarian carcinoma beta-N-acetylglucosaminidase isoenzymes and their role in extracellular matrix degradation. Cancer Res 1989; 49 (20): 5598-604.
12. Wrodnigg TM, Steiner AJ, Ueberbacher BJ. Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy. Anticancer Agents Med Chem 2008; 8 (1): 77-85.
13. Rountree JS, Butters TD, Wormald MR et al. Design, synthesis and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease. Chem Med Chem 2009; 4 (3): 378-92.
14. Lasfargues EY, Coutinho WG, Redfield ES. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J Natl Cancer Inst 1978; 61 (4): 967-97.
15. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978; 38 (10): 3352-64.
16. Cailleau R, Young R, Olive M, Reeves WJ. Breast tumour cell lines from pleural effusions. J Natl Cancer Inst 1974; 53 (3): 661-673.
17. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human breast cancer cell line from pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51 (5): 1409-16.
18. Stamps AC, Davies SC, Burman J, O'Hare MJ. Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Int J Cancer 1994; 57 (6): 865-74.
19. Perou CM, Sørlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406 (6797): 747-52.
20. Jönsson G, Staaf J, Olsson E et al. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007; 46 (6): 543-58.
21. Kilian M, Bulow P. Rapid diagnosis of Enterobacteriaceae I. Detection of bacterial glycosidases. Acta Pathol Microbial Scand B 1976; 84B (5): 245-51.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
23. Thompson AL, Michalik A, Nash RJ et al. Steviamine, a new class of indolizidine alkaloid [(1R,2S,3R,5R,8aR)-3-(Hydroxymethyl)-5- methyloctahydroindolizine-1,2-diol hydrobromide]. Acta Cryslallogr C 2009; E65: o2904-5 (doi:10.1107/S1600536809043827).
24. Slawson C, Pidala J, Potter R. Increased N-acetyl-β-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetyl-glucosamine containing proteins. Biochim Biophys Acta 2001; 1537: 147-57.
25. Martino S, Emiliani C, Tabilio A, Falzetti F, Stirling JL, Orlacchio A. Distribution of active alpha- and beta-subunits of beta-N-acetylhexosaminidase as a function of leukaemic cell types. Biochim Biophys Acta 1997; 1335 (1-2): 5-15. (Pubitemid 27174501)
26. Alhadeff JA, Holzinger RT. Presence of an atypical thermolabile species of beta-hexosaminidase B in metastatic tumour tissue of human liver. Biochem J 1982; 201 (1): 95-9.
27. Dong JM, Sahagian GG. Basis for low affinity binding of a lysosomal cysteine protease to the cation-independent mannose 6-phosphate receptor. J Biol Chem 1990; 265 (8): 4210-7.
28. Varki A. Glycosylation changes in cancer. In: Varki A, Esko J, Cummings R, Freeze HH, Hart GW, Marth J eds. Essentials of glycobiology. Plainview NY: Cold Spring Harbor Laboratory Press, 1999.
29. Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000; 19: 6642-50. (Pubitemid 32197703)
30. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002; 295 (5564): 2387-92.